>>
You will find below the elements identified by the HONcode team at a precise date to justify the respect of the 8 ethical principles.
The content of this certificate has been collected and written by the Health On the Net Foundation (HON) and should not be used without previous permission granted by HON. A request for permission can be sent to:
HON.
|
| 1. Information must be authoritative |
This site was developed by Dr. Scott Farrell, Professor and Head of the Urogynaecology Division of the Department of Obstetrics and Gynaecology, Dalhousie University in Halifax, Nova Scotia; Karen Farrell, BSc., masters candidate in Health Education at the School of Health and Human Performance, Dalhousie University, Halifax, Nova Scotia; and Ryan Grant, senior web designer at Nicom Ltd., Dartmouth, Nova Scotia.
(11 Sep 2011) -
|
2. Presentation of the site Mission:
|
It is designed to provide incontinent women with information so they may make informed choices about their health.
(11 Sep 2011) -
|
| Audience:
|
This site has been developed by health professionals experienced in caring for women who suffer from involuntary loss of urine (urinary incontinence).
(11 Sep 2011) -
|
| Purpose of the website
|
It is meant to support, not replace, the relationship that exists between a site visitor and her healthcare provider.
(11 Sep 2011) -
|
| 3. Confidentiality |
This site does not collect any personal identifying information from visitors.
(11 Sep 2011) -
|
| 4. Information must be documented: Referenced and dated |
| Only data for one sample are displayed among those selected. |
Additional References (other sources): I. General Information About Urinary Incontinence Campbell AJ, Reinken J, McCosh L. Incontinence in the elderly: prevalence and prognosis. Age Ageing 1985:14:65-70.
(11 Sep 2011) -
|
|
|
Last Modified: 03.05.04
(02 Sep 2010) -
|
| 5. Justification of claims |
Anti-cholinergic Medications: These medications discourage tightening of the bladder muscles before the bladder is full. They reduce the feeling of urgency. Examples:"Pro-Banthine"® (Propantheline Bromide) and "Detrol"® (Tolterodine).
(11 Sep 2011) -
|
| 6. User support and adequation |
Contact Webmaster
(11 Sep 2011) -
|
|
|
| 7. Disclosure of funding sources |
This site is funded by Dr. Farrell's personal research and development funds.
(11 Sep 2011) -
|
| 8. Advertising policy |
http://www.uresta.com
(03 Sep 2009) -
|
No advertising is hosted on this website and no funding from advertising is received.
(11 Sep 2011) -
|